1. Home
  2. MRUS vs EAT Comparison

MRUS vs EAT Comparison

Compare MRUS & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • EAT
  • Stock Information
  • Founded
  • MRUS 2003
  • EAT 1975
  • Country
  • MRUS Netherlands
  • EAT United States
  • Employees
  • MRUS N/A
  • EAT N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • EAT Restaurants
  • Sector
  • MRUS Health Care
  • EAT Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • EAT Nasdaq
  • Market Cap
  • MRUS 3.6B
  • EAT 3.2B
  • IPO Year
  • MRUS 2016
  • EAT N/A
  • Fundamental
  • Price
  • MRUS $46.58
  • EAT $117.41
  • Analyst Decision
  • MRUS Strong Buy
  • EAT Hold
  • Analyst Count
  • MRUS 10
  • EAT 19
  • Target Price
  • MRUS $86.70
  • EAT $85.38
  • AVG Volume (30 Days)
  • MRUS 376.4K
  • EAT 1.5M
  • Earning Date
  • MRUS 10-31-2024
  • EAT 10-30-2024
  • Dividend Yield
  • MRUS N/A
  • EAT N/A
  • EPS Growth
  • MRUS N/A
  • EAT 31.88
  • EPS
  • MRUS N/A
  • EAT 4.07
  • Revenue
  • MRUS $35,932,000.00
  • EAT $4,541,600,000.00
  • Revenue This Year
  • MRUS N/A
  • EAT $8.83
  • Revenue Next Year
  • MRUS $52.49
  • EAT $3.66
  • P/E Ratio
  • MRUS N/A
  • EAT $28.83
  • Revenue Growth
  • MRUS N/A
  • EAT 8.39
  • 52 Week Low
  • MRUS $22.26
  • EAT $34.77
  • 52 Week High
  • MRUS $61.61
  • EAT $123.66
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 32.37
  • EAT 73.69
  • Support Level
  • MRUS $48.42
  • EAT $110.62
  • Resistance Level
  • MRUS $53.49
  • EAT $123.66
  • Average True Range (ATR)
  • MRUS 2.17
  • EAT 3.97
  • MACD
  • MRUS -0.54
  • EAT 0.40
  • Stochastic Oscillator
  • MRUS 5.73
  • EAT 77.73

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

Share on Social Networks: